ABSTRACT
A patient in her mid-30s presented to hospital at 25 weeks' gestation with acute onset of leg pain.Routine investigations were performed to rule out the common causes of leg and back pain in pregnancy, which were grossly normal. Piriformis pyomyositis was diagnosed on MRI and a collection was drained. Following an initial response to antibiotic therapy, the patient delivered by elective caesarean section, but the pain returned on postnatal day 2 and muscle inflammation was diagnosed again, requiring a repeat course of antibiotics.This case highlights a rare cause of leg pain in a pregnant patient, and the additional complexities of managing cases in the obstetric population.
Subject(s)
Myositis , Pyomyositis , Anti-Bacterial Agents/therapeutic use , Cesarean Section , Female , Humans , Muscle, Skeletal/diagnostic imaging , Myositis/complications , Myositis/diagnosis , Myositis/drug therapy , Pain/drug therapy , Pregnancy , Pyomyositis/diagnosis , Pyomyositis/drug therapyABSTRACT
CONTEXT.: A severe third wave of COVID-19 disease affected Ireland in the first 3 months of 2021. In this wave, 1 second-trimester miscarriage and 6 stillbirths were observed in the Irish population because of placental insufficiency as a result of SARS-CoV-2 placentitis. This observation was at odds with the country's previous experience with COVID-19 disease in pregnant mothers. OBJECTIVE.: To describe the clinical and pathologic features of these pregnancy losses. DESIGN.: Retrospective review of clinical and pathologic data of cases of second-trimester miscarriage, stillbirth, or neonatal death identified by perinatal pathologists as being due to SARS-CoV-2 placentitis during the third wave of COVID-19 in Ireland. RESULTS.: Clinical and pathologic data were available for review in 6 pregnancies. Sequencing or genotyping of the virus identified SARS-CoV-2 alpha (B.1.1.7) in all cases. Three of the 6 cases had maternal thrombocytopenia, and fetal growth restriction was not prominent, suggesting a rapidly progressive placental disease. CONCLUSIONS.: The identification of SARS-CoV-2 alpha in all these cases suggests that the emergence of the variant was associated with an increased risk of fetal death due to SARS-CoV-2 placentitis when compared with the original virus. Maternal thrombocytopenia may have potential as a clinical marker of placentitis, but other inflammatory markers need investigation. Three of the 6 women had been assessed for reduced fetal movements in hospital some days before the fetal deaths actually occurred; this could suggest that there may be a window for intervention in some cases.
Subject(s)
Abortion, Spontaneous , COVID-19 , Pregnancy Complications, Infectious , Thrombocytopenia , Abortion, Spontaneous/epidemiology , Abortion, Spontaneous/pathology , Female , Fetal Death/etiology , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical , Ireland/epidemiology , Male , Placenta/pathology , Pregnancy , Pregnancy Complications, Infectious/pathology , SARS-CoV-2 , Stillbirth/epidemiologyABSTRACT
The peripheral nerve contains diverse cell types that support its proper function and maintenance. In this study, we analyzed multiple peripheral nerves using single-nuclei RNA sequencing, which allowed us to circumvent difficulties encountered in analyzing cells with complex morphologies via conventional single-cell methods. The resultant mouse peripheral nerve cell atlas highlights a diversity of cell types, including multiple subtypes of Schwann cells (SCs), immune cells and stromal cells. We identified a distinct myelinating SC subtype that expresses Cldn14, Adamtsl1 and Pmp2 and preferentially ensheathes motor axons. The number of these motor-associated Pmp2+ SCs is reduced in both an amyotrophic lateral sclerosis (ALS) SOD1G93A mouse model and human ALS nerve samples. Our findings reveal the diversity of SCs and other cell types in peripheral nerve and serve as a reference for future studies of nerve biology and disease.
Subject(s)
Amyotrophic Lateral Sclerosis , Amyotrophic Lateral Sclerosis/metabolism , Animals , Disease Models, Animal , Mice , Mice, Transgenic , Neuroglia/metabolism , Peripheral Nerves/metabolism , Schwann Cells/metabolism , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolismABSTRACT
On September 6 and 20, 2017, Hurricanes Irma and Maria made landfall as major hurricanes in the US Caribbean Territories of the Virgin Islands and Puerto Rico with devastating effects. As part of the initial response, a public health team (PHT) was initially deployed as part of the US Department of Health and Human Services Incident Response Coordination Team. As a result of increased demands for additional expertise and resources, a public health branch (PHB) was established for coordinating a broad spectrum of public health response activities in support of the affected territories. This paper describes the conceptual framework for organizing these activities; summarizes some key public health activities and roles; outlines partner support and coordination with key agencies; and defines best practices and areas for improvement in disaster future operations.
Subject(s)
Cyclonic Storms , Federal Government , Humans , Public Health , Puerto Rico , United States Virgin IslandsABSTRACT
The segregation and myelination of axons in the developing PNS, results from a complex series of cellular and molecular interactions between Schwann cells and axons. Previously we identified the Lgi4 gene (leucine-rich glioma-inactivated4) as an important regulator of myelination in the PNS, and its dysfunction results in arthrogryposis as observed in claw paw mice. Lgi4 is a secreted protein and a member of a small family of proteins that are predominantly expressed in the nervous system. Their mechanism of action is unknown but may involve binding to members of the Adam (A disintegrin and metalloprotease) family of transmembrane proteins, in particular Adam22. We found that Lgi4 and Adam22 are both expressed in Schwann cells as well as in sensory neurons and that Lgi4 binds directly to Adam22 without a requirement for additional membrane associated factors. To determine whether Lgi4-Adam22 function involves a paracrine and/or an autocrine mechanism of action we performed heterotypic Schwann cell sensory neuron cultures and cell type-specific ablation of Lgi4 and Adam22 in mice. We show that Schwann cells are the principal cellular source of Lgi4 in the developing nerve and that Adam22 is required on axons. Our results thus reveal a novel paracrine signaling axis in peripheral nerve myelination in which Schwann cell secreted Lgi4 functions through binding of axonal Adam22 to drive the differentiation of Schwann cells.
Subject(s)
ADAM Proteins/physiology , Extracellular Matrix Proteins/genetics , Extracellular Matrix Proteins/metabolism , Nerve Tissue Proteins/physiology , Schwann Cells/physiology , Sensory Receptor Cells/metabolism , Signal Transduction/genetics , ADAM Proteins/biosynthesis , ADAM Proteins/genetics , ADAM Proteins/metabolism , Animals , Animals, Newborn , Cell Line , Cells, Cultured , Extracellular Matrix Proteins/physiology , Humans , Mice , Mice, Knockout , Mice, Transgenic , Myelin Sheath/genetics , Myelin Sheath/physiology , Myelin Sheath/ultrastructure , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Protein Binding/genetics , Rats , Schwann Cells/metabolism , Schwann Cells/ultrastructure , Sensory Receptor Cells/physiology , Sensory Receptor Cells/ultrastructureABSTRACT
Struma ovarii is a rare dermoid tumor that consists of more than 50% thyroid tissue. The incidence of struma ovarii is reported to be 1% of all ovarian tumors and 2-5% of all ovarian teratomas. The authors present a case of struma ovarii diagnosed during the first trimester of pregnancy in a primigravida patient and discuss the clinical presentation, diagnosis, and management options for such rare tumors, both in and outside of pregnancy.
ABSTRACT
Peripheral neuropathy is a broad category of disorders with a diverse etiology, grouped together by their common pathogenic effect on the peripheral nervous system (PNS). Because of the heterogeneity observed to be responsible for these disorders, a forward genetics method of gene discovery was used to identify additional affected pathways. In this report, we describe the mutant mouse line 20884, generated by N-ethyl-N-nitrosourea mutagenesis, which is characterized by adult-onset transitory hindlimb paralysis. Linkage mapping revealed that two point mutations are responsible for the phenotype: a partial loss-of-function mutation in the gene for phosphatidate phosphatase Lpin1 and a truncation mutation in the gene that encodes the neuronal cell adhesion molecule NrCAM. To investigate how the 20884 Lpin1 and Nrcam mutations interact to produce the paralysis phenotype, the double mutant and both single mutants were analyzed by quantitative behavioral, histological, and electrophysiological means. The Lpin1(20884) mutant and the double mutant are characterized by similar levels of demyelination and aberrant myelin structures. Nevertheless, the double mutant exhibits more severe electrophysiological abnormalities than the Lpin1(20884) mutant. The Nrcam(20884) mutant is characterized by normal sciatic nerve morphology and a mild electrophysiological defect. Comparison of the double mutant phenotype with the two single mutants does not point to an additive relationship between the two defects; rather, the Lpin1(20884) and Nrcam(20884) defects appear to act synergistically to produce the 20884 phenotype. It is proposed that the absence of NrCAM in a demyelinating environment has a deleterious effect, possibly by impairing the process of remyelination.
Subject(s)
Cell Adhesion Molecules/genetics , Mutation/genetics , Nuclear Proteins/genetics , Paraplegia/genetics , Peripheral Nervous System Diseases/genetics , Animals , Hindlimb , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Neurologic Mutants , Paraplegia/physiopathology , Peripheral Nervous System Diseases/physiopathology , Phosphatidate PhosphataseABSTRACT
Related transcription factors of the POU protein family show extensive overlap of expression in vivo and exhibit very similar biochemical properties in vitro. To study functional equivalence of class III POU proteins in vivo, we exchanged the Oct-6 gene by Brn-1 in the mouse. Brn-1 can fully replace Oct-6 in Schwann cells and rescue peripheral nervous system development in these mice. The same mice, however, exhibit severe defects in forebrain development arguing that Oct-6 and Brn-1 are not functionally equivalent in the central nervous system. The cause of the observed forebrain phenotype is complex, but anteriorly expanded Wnt1 expression contributes. Oct-6 normally represses Wnt1 expression in the early diencephalon and replacement by Brn-1 as a weaker inhibitor is no longer sufficient to maintain the necessary level of repression in the mouse mutant. The extent of functional equivalence between related transcription factors is thus strongly dependent on the analyzed tissue.
Subject(s)
Nerve Tissue Proteins/metabolism , Octamer Transcription Factor-6/metabolism , POU Domain Factors/metabolism , Prosencephalon , Animals , Biomarkers/metabolism , Cell Line , Humans , In Situ Hybridization , Mesencephalon/embryology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Nerve Tissue Proteins/genetics , Neural Crest/physiology , Octamer Transcription Factor-6/genetics , POU Domain Factors/genetics , Phenotype , Prosencephalon/abnormalities , Prosencephalon/embryology , Rhombencephalon/embryology , Wnt1 Protein/genetics , Wnt1 Protein/metabolismABSTRACT
Peripheral nerve development results from multiple cellular interactions between axons, Schwann cells and the surrounding mesenchymal tissue. The delayed axonal sorting and hypomyelination throughout the peripheral nervous system of claw paw (clp) mutant mice suggest that the clp gene product is critical for these interactions. Here we identify the clp mutation as a 225-bp insertion in the Lgi4 gene. Lgi4 encodes a secreted and glycosylated leucine-rich repeat protein and is expressed in Schwann cells. The clp mutation affects Lgi4 mRNA splicing, resulting in a mutant protein that is retained in the cell. Additionally, siRNA-mediated downregulation of Lgi4 in wild-type neuron-Schwann cell cocultures inhibits myelination, whereas exogenous Lgi4 restores myelination in clp/clp cultures. Thus, the abnormalities observed in clp mice are attributable to the loss of Lgi4 function, and they identify Lgi4 as a new component of Schwann cell signaling pathway(s) that controls axon segregation and myelin formation.
Subject(s)
Foot Deformities/genetics , Mutation/physiology , Peripheral Nervous System/growth & development , Peripheral Nervous System/physiology , Proteins/physiology , Amino Acid Sequence , Animals , Axons/physiology , Base Sequence , Cloning, Molecular , Coculture Techniques , DNA Transposable Elements , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Down-Regulation/genetics , Down-Regulation/physiology , Gene Expression Regulation/genetics , Gene Expression Regulation/physiology , Genetic Complementation Test , Genotype , Immunohistochemistry , In Situ Hybridization , Lentivirus/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Molecular Sequence Data , Myelin Sheath/physiology , Nerve Tissue Proteins , Neurons, Afferent/physiology , Phenotype , Proteins/genetics , RNA, Small Interfering/genetics , Rats , Reverse Transcriptase Polymerase Chain Reaction , Schwann Cells/physiology , TransfectionABSTRACT
Accumulation of Na(+) channels at the nodes of Ranvier is a prerequisite for saltatory conduction. In peripheral nerves, clustering of these channels along the axolemma is regulated by myelinating Schwann cells through a yet unknown mechanism. We report the identification of gliomedin, a glial ligand for neurofascin and NrCAM, two axonal immunoglobulin cell adhesion molecules that are associated with Na+ channels at the nodes of Ranvier. Gliomedin is expressed by myelinating Schwann cells and accumulates at the edges of each myelin segment during development, where it aligns with the forming nodes. Eliminating the expression of gliomedin by RNAi, or the addition of a soluble extracellular domain of neurofascin to myelinating cultures, which caused the redistribution of gliomedin along the internodes, abolished node formation. Furthermore, a soluble gliomedin induced nodal-like clusters of Na+ channels in the absence of Schwann cells. We propose that gliomedin provides a glial cue for the formation of peripheral nodes of Ranvier.
Subject(s)
Axons/metabolism , Cell Adhesion Molecules/metabolism , Macromolecular Substances/metabolism , Ranvier's Nodes/metabolism , Schwann Cells/metabolism , Age Factors , Amino Acid Sequence , Animals , Ankyrins/metabolism , Blotting, Northern/methods , Blotting, Western/methods , Cell Adhesion Molecules/immunology , Cell Adhesion Molecules, Neuronal/metabolism , Cell Compartmentation , Cells, Cultured , Chlorocebus aethiops , Claudins , Cloning, Molecular/methods , Cytoskeletal Proteins , Fluorescent Antibody Technique/methods , Ganglia, Spinal/metabolism , Gene Expression Regulation, Developmental , Humans , Macromolecular Substances/immunology , Membrane Proteins/metabolism , Microfilament Proteins/metabolism , Microscopy, Immunoelectron/methods , Myelin Basic Protein/metabolism , Myelin-Associated Glycoprotein/metabolism , Neurofilament Proteins/metabolism , Phosphoproteins/metabolism , Protein Binding/physiology , Protein Structure, Tertiary , Ranvier's Nodes/ultrastructure , Rats , Receptors, Peptide/metabolism , S100 Proteins/metabolism , Schwann Cells/ultrastructure , Sciatic Nerve/growth & development , Sciatic Nerve/metabolism , Sodium Channels/metabolism , Spectrin/metabolism , Transfection/methodsABSTRACT
Of the 617 genes from Buchnera aphidicola, the obligate bacterial symbiont of the pea aphid, 23% were differentially expressed in embryos compared to adults. Genes involved in flagellar apparatus and riboflavin synthesis exhibited particularly robust upregulation in embryos, suggesting functional differences between the symbiosis in the adult and embryo insect.
Subject(s)
Aphids/microbiology , Buchnera/genetics , Buchnera/metabolism , Gene Expression Profiling , Symbiosis/physiology , Aging , Animals , Embryo, Nonmammalian/metabolism , Gene Expression Regulation, Bacterial , Genes, Bacterial/genetics , Molecular Sequence Data , Oligonucleotide Array Sequence Analysis , Reproducibility of Results , Up-RegulationABSTRACT
Despite the importance of myelinating Schwann cells in health and disease, little is known about the genetic mechanisms underlying their development. The POU domain transcription factor pou3f1 (Tst-1, SCIP, Oct-6) is required for the normal differentiation of myelinating Schwann cells, but its precise role requires identification of the genes that it regulates. Here we report the isolation of six genes whose expression is reduced in the absence of pou3f1. Only one of these genes, the fatty acid transport protein P2, was known previously to be expressed in Schwann cells. The LIM domain proteins cysteine-rich protein-1 (CRP1) and CRP2 are expressed in sciatic nerve and induced by forskolin in cultured Schwann cells, but only CRP2 requires pou3f1 for normal expression. pou3f1 appears to require the claw paw gene product for activation of at least some of its downstream effector genes. Expression of the novel Schwann cell genes after nerve injury suggests that they are myelin related. One of the genes, tramdorin1, encodes a novel amino acid transport protein that is localized to paranodes and incisures. Our results suggest that pou3f1 functions to activate gene expression in the differentiation of myelinating Schwann cells.
Subject(s)
Avian Proteins , Down-Regulation/physiology , Gene Expression Profiling , Sciatic Nerve/metabolism , Sciatic Neuropathy/metabolism , Transcription Factors/deficiency , Adaptor Proteins, Signal Transducing , Amino Acid Transport Systems/physiology , Animals , CCAAT-Enhancer-Binding Protein-beta/metabolism , Carrier Proteins/metabolism , Cell Differentiation/physiology , Cell Membrane/metabolism , Cells, Cultured , Colforsin/pharmacology , Cytoskeleton/metabolism , Disease Models, Animal , Down-Regulation/drug effects , LIM Domain Proteins , Mice , Mice, Mutant Strains , Myelin Sheath/metabolism , Octamer Transcription Factor-6 , Protein Structure, Tertiary/physiology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Schwann Cells/cytology , Schwann Cells/drug effects , Schwann Cells/metabolism , Sciatic Nerve/injuries , Transcription Factors/genetics , Transcription Factors/metabolismABSTRACT
The development and function of the vertebrate nervous system depend on specific interactions between different cell types. Two examples of such interactions are synaptic transmission and myelination. LGI1-4 (leucine-rich glioma inactivated proteins) play important roles in these processes. They are secreted proteins consisting of an LRR (leucine-rich repeat) domain and a so-called epilepsy-associated or EPTP (epitempin) domain. Both domains are thought to function in protein-protein interactions. The first LGI gene to be identified, LGI1, was found at a chromosomal translocation breakpoint in a glioma cell line. It was subsequently found mutated in ADLTE (autosomal dominant lateral temporal (lobe) epilepsy) also referred to as ADPEAF (autosomal dominant partial epilepsy with auditory features). LGI1 protein appears to act at synapses and antibodies against LGI1 may cause the autoimmune disorder limbic encephalitis. A similar function in synaptic remodelling has been suggested for LGI2, which is mutated in canine Benign Familial Juvenile Epilepsy. LGI4 is required for proliferation of glia in the peripheral nervous system and binds to a neuronal receptor, ADAM22, to foster ensheathment and myelination of axons by Schwann cells. Thus, LGI proteins play crucial roles in nervous system development and function and their study is highly important, both to understand their biological functions and for their therapeutic potential. Here, we review our current knowledge about this important family of proteins, and the progress made towards understanding their functions.
Subject(s)
Nerve Tissue Proteins/genetics , Nervous System Physiological Phenomena/genetics , Amino Acid Sequence , Animals , Autoimmune Diseases/genetics , Biological Evolution , Dogs , Glioma/metabolism , Humans , Limbic Encephalitis/genetics , Limbic Encephalitis/metabolism , Molecular Sequence Data , Mutation/physiology , Nerve Tissue Proteins/physiology , Nervous System/growth & development , Nervous System Neoplasms/metabolism , Peripheral Nervous System/physiology , Protein Conformation , Protein Processing, Post-Translational/genetics , Rats , Zebrafish , Zebrafish ProteinsABSTRACT
Fibroblasts and smooth muscle cells (FSMCs) are principal cell types of connective and adventitial tissues that participate in the development, physiology and pathology of internal organs, with incompletely defined cellular origins. Here, we identify and prospectively isolate from the mesothelium a mouse cell lineage that is committed to FSMCs. The mesothelium is an epithelial monolayer covering the vertebrate thoracic and abdominal cavities and internal organs. Time-lapse imaging and transplantation experiments reveal robust generation of FSMCs from the mesothelium. By targeting mesothelin (MSLN), a surface marker expressed on mesothelial cells, we identify and isolate precursors capable of clonally generating FSMCs. Using a genetic lineage tracing approach, we show that embryonic and adult mesothelium represents a common lineage to trunk FSMCs, and trunk vasculature, with minimal contributions from neural crest, or circulating cells. The isolation of FSMC precursors enables the examination of multiple aspects of smooth muscle and fibroblast biology as well as the prospective isolation of these precursors for potential regenerative medicine purposes.
Subject(s)
Epithelium/metabolism , Fibroblasts/cytology , Myocytes, Smooth Muscle/cytology , Animals , Fibroblasts/drug effects , Flow Cytometry , GPI-Linked Proteins/metabolism , Gastrointestinal Tract/cytology , Gastrointestinal Tract/drug effects , Gastrointestinal Tract/metabolism , Genotype , Immunohistochemistry , Mesothelin , Mice , Mice, Transgenic , Myocytes, Smooth Muscle/drug effects , Tamoxifen/pharmacologyABSTRACT
The transition from juvenile to adult life is accompanied by programmed remodeling in many tissues and organs, which is key for organisms to adapt to the demand of the environment. Here we report a novel regulated alternative splicing program that is crucial for postnatnal heart remodeling in the mouse. We identify the essential splicing factor ASF/SF2 as a key component of the program, regulating a restricted set of tissue-specific alternative splicing events during heart remodeling. Cardiomyocytes deficient in ASF/SF2 display an unexpected hypercontraction phenotype due to a defect in postnatal splicing switch of the Ca(2+)/calmodulin-dependent kinase IIdelta (CaMKIIdelta) transcript. This failure results in mistargeting of the kinase to sarcolemmal membranes, causing severe excitation-contraction coupling defects. Our results validate ASF/SF2 as a fundamental splicing regulator in the reprogramming pathway and reveal the central contribution of ASF/SF2-regulated CaMKIIdelta alternative splicing to functional remodeling in developing heart.
Subject(s)
Alternative Splicing , Calcium-Calmodulin-Dependent Protein Kinases/genetics , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Myocardial Contraction/physiology , Myocytes, Smooth Muscle/physiology , Nuclear Proteins/metabolism , Animals , Calcium-Calmodulin-Dependent Protein Kinase Type 2 , Exons , Female , Gene Expression Regulation, Developmental , Humans , In Vitro Techniques , Isoenzymes/genetics , Isoenzymes/metabolism , Male , Mice , Mice, Knockout , Nuclear Proteins/genetics , Phenotype , RNA-Binding Proteins , Serine-Arginine Splicing Factors , TransfectionABSTRACT
Three closely related genes encoding amino acid transport proteins are clustered on 5q32 in humans, and Chromosome (Chr) 11 in mice. The human SLC36A1 gene, which encodes the lysosomal amino acid transporter LYAAT1/PAT1, generates multiple alternative mRNAs, some of which encode truncated proteins. SLC36A1 is expressed in numerous tissues, whereas expression of SLC36A2, which encodes the glycine transporter tramdorinl/PAT2, is most abundant in kidney and muscle. Expression of a third gene, SLC36A3, is restricted to testis. Mouse Slc36a2 also is expressed in bone and fat tissue. Polymorphisms in human SLC36A2 exclude it as a candidate locus for a peripheral neuropathy that has been mapped to 5q31-33. SLC36A2 is a candidate gene for 5q-myelodysplastic syndrome, on the basis of its chromosomal location and its expression in bone.